Recruiting at 1 site No phase Stress Disorders, Post-Traumatic

Stress Disorders, Post-Traumatic study: Cognitive Processing Therapy

Official title Enhancing Memory in Cognitive Processing Therapy for PTSD

ClinicalTrials.gov ID: NCT06000475

What this study is testing

What it's testing
The study wants to see if adding a memory‑enhancement method to cognitive processing therapy helps older veterans learn the therapy better and improve their PTSD symptoms.
Who it's for
Older adults (typically veterans) who have post‑traumatic stress disorder and are not fully responding to standard therapy.
What's involved
Participants will receive the usual cognitive processing therapy and an extra memory‑boosting activity during sessions. They will attend regular therapy visits and may do short memory exercises.
Time commitment
The study lasts about 12 weeks, with weekly therapy sessions and occasional check‑ins to track progress.
  • Which group you join is decided by chance.

A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.

Who can take part

Ages 60 and older

You may be able to join if

  • Veterans with DSM-5 diagnoses of PTSD via the Clinician Administered PTSD Scale (CAPS-5)

You likely can't join if

  • daily benzodiazepine use (due to memory impairing effects)
  • bipolar or psychotic disorders
  • current suicidal ideation with plan or intent
  • current moderate or severe substance use disorder not in remission for \>1 month
  • severe traumatic brain injury
  • a Montreal Cognitive Assessment (MoCA) indicative of dementia
See the full eligibility criteria
Who can join
  • Veterans with DSM-5 diagnoses of PTSD via the Clinician Administered PTSD Scale (CAPS-5)
What rules you out
  • daily benzodiazepine use (due to memory impairing effects)
  • bipolar or psychotic disorders
  • current suicidal ideation with plan or intent
  • current moderate or severe substance use disorder not in remission for \>1 month
  • severe traumatic brain injury
  • a Montreal Cognitive Assessment (MoCA) indicative of dementia
  • or other disorders that would severely limit study participation

The study team makes the final eligibility decision.

Where it is enrolling

  • Philadelphia, Pennsylvania, United States

Questions & answers

Do participants get paid in this trial?

This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.

Is it free to join, and do I need insurance?

Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.

How long does this study last?

The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.

Who can join this trial?

This study is enrolling all sexes, 60 years and older. The study team makes the final eligibility decision.

Where is this trial taking place?

This study is enrolling now at Philadelphia, Pennsylvania, United States. Enter your location above to see the nearest enrolling site and check your eligibility.

Explore other conditions

BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.